Chapter 3 New Insights on Mast Cell Activation via the High Affinity Receptor for IgE1

Advances in Immunology

Volumn 98, Issue , 2008, Pages 85-120

  Rivera, Juan ^a   Fierro, Nora A ^a   Olivera, Ana ^a   Suzuki, Ryo ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

Calcium; Fc RI; IgE; Kinase; Mast Cell

Indexed keywords

ANTIGEN; CALCIUM; IMMUNOGLOBULIN E RECEPTOR; LIPID; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PROTEIN KINASE FYN; PROTEIN KINASE LYN; PROTEIN KINASE SYK; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE KINASE; DRUG DERIVATIVE; LYN PROTEIN-TYROSINE KINASE; LYSOPHOSPHOLIPID; PROTEIN TYROSINE KINASE; SPHINGOSINE; SPHINGOSINE 1-PHOSPHATE; UNCLASSIFIED DRUG;

CALCIUM MOBILIZATION; CELL ACTIVATION; CELL FUNCTION; COMPREHENSION; ENVIRONMENT; ENZYME ACTIVATION; GENETIC DIFFERENCE; GENETICS; HUMAN; IN VIVO STUDY; INTROSPECTION; LIPID RAFT; LIQUID; MAST CELL; MOLECULAR MECHANICS; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVIEW; ANIMAL; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CALCIUM; HUMANS; LYSOPHOSPHOLIPIDS; MAST CELLS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-FYN; RECEPTORS, IGE; RECEPTORS, LYSOSPHINGOLIPID; SIGNAL TRANSDUCTION; SPHINGOSINE; SRC-FAMILY KINASES;

EID: 50349095048     PISSN: 00652776     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2776(08)00403-3     Document Type: Review

References (128)

1. Ali K., Bilancio A., Thomas M., Pearce W., Gilfillan A.M., Tkaczyk C., Kuehn N., Gray A., Giddings J., Peskett E., Fox R., Bruce I., et al. Essential role for the p110δ phosphoinositide 3-kinase in the allergic response. Nature 431 (2004) 1007-1011
2. Allende M.L., and Proia R.L. Sphingosine-1-phosphate receptors and the development of the vascular system. Biochim. Biophys. Acta. 1582 (2002) 222-227
3. Allende M.L., Sasaki T., Kawai H., Olivera A., Mi Y., van Echten-Deckert G., Hajdu R., Rosenbach M., Keohane C.A., Mandala S., Spiegel S., and Proia R.L. Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720. J. Biol. Chem. 279 (2004) 52487-52492
4. Ammit A.J., Hastie A.T., Edsall L.C., Hoffman R.K., Amrani Y., Krymskaya V.P., Kane S.A., Peters S.P., Penn R.B., Spiegel S., and Panettieri Jr. R.A. Sphingosine 1-phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthma. Faseb. J. 15 (2001) 1212-1214
5. Baba Y., Nishida K., Fujii Y., Hirano T., Hikida M., and Kurosaki T. Essential function for the calcium sensor STIM1 in mast cell activation and anaphylactic responses. Nat. Immunol. 9 (2008) 81-88
6. Barker S.A., Caldwell K.K., Hall A., Martinez A.M., Pfeiffer J.R., Oliver J.M., and Wilson B.S. Wortmannin blocks lipid and protein kinase activities associated with PI 3-kinase and inhibits a subset of responses induced by FcεRI cross-linking. Mol. Biol. Cell 6 (1995) 1145-1158
7. 2+ mobilization in antigen-stimulated mast cells. J. Leukocyte Biol. 65 (1999) 321-329
8. Beavitt S.J., Harder K.W., Kemp J.M., Jones J., Quilici C., Casagranda F., Lam E., Turner D., Brennan S., Sly P.D., Tarlinton D.M., and Anderson G.P. Lyn-deficient mice develop severe, persistent asthma: Lyn is a critical negative regulator of Th2 immunity. J. Immunol. 175 (2005) 1867-1875
9. Becker K.P., and Hannun Y.A. Protein kinase C and phospholipase D: Intimate interactions in intracellular signaling. Cell Mol. Life Sci. 62 (2005) 1448-1461
10. syk in high affinity receptor signaling. Identification as a component of pp72 and associaition with the receptor γ chain after receptor aggregation. J. Biol. Chem. 268 (1993) 23318-23324
11. Berton G., Mocsai A., and Lowell C.A. Src and Syk kinases: Key regulators of phagocytic cell activation. Trends Immunol. 26 (2005) 208-214
12. Blank U., and Rivera J. The Ins and Outs of IgE-dependent mast cell exocytosis. Trends Immunol. 25 (2004) 266-273
13. Choi O.H., Kim J.H., and Kinet J.P. Calcium mobilization via sphingosine kinase in signalling by the FcεRI antigen receptor. Nature 380 (1996) 634-636
14. Costello P.S., Turner M., Walters A.E., Cunningham C.N., Bauer P.H., Downward J., and Tybulewicz V.L.J. Critical role for the tyrosine kinase Syk in signalling through the high affinity IgE receptor of mast cells. Oncogene 13 (1996) 2595-2605
15. Davey A.M., Krise K.M., Sheets E.D., and Heikal A.A. Molecular perspective of antigen-mediated mast cell signaling. J. Biol. Chem. 283 (2008) 7117-7127
16. Davey A.M., Walvick R.P., Liu Y., Heikal A.A., and Sheets E.D. Membrane order and molecular dynamics associated with IgE receptor cross-linking in mast cells. Biophys. J. 92 (2007) 343-355
17. Delon C., Manifava M., Wood E., Thompson D., Krugmann S., Pyne S., and Ktistakis N.T. Sphingosine kinase 1 is an intracellular effector of phosphatidic acid. J. Biol. Chem. 279 (2004) 44763-44774
18. 2+ signaling in mast cells by tyrosine-phosphorylated and unphosphorylated non-T cell activation linker. J. Immunol. 179 (2007) 5169-5180
19. Feske S., Gwack Y., Prakriya M., Srikanth S., Puppel S.H., Tanasa B., Hogan P.G., Lewis R.S., Daly M., and Rao A. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 441 (2006) 179-185
20. Field K.A., Holowka D., and Baird B. Compartmentalized activation of the high affinity immunoglobulin E receptor within membrane domains. J. Biol. Chem. 272 (1997) 4276-4280
21. Furumoto Y., Brooks S., Olivera A., Takagi Y., Miyagishi M., Taira K., Casellas R., Beaven M.A., Gilfillan A.M., and Rivera J. Cutting Edge: Lentiviral shRNA silencing of PTEN in human mast cells reveals constitutive signals that promote cytokine secretion and cell survival. J. Immunol. 176 (2006) 5167-5171
22. Furumoto Y., Nunomura S., Terada T., Rivera J., and Ra C. The FcεRIβ immunoreceptor tyrosine-based activation motif exerts inhibitory control on MAPK and IκB kinase phosphorylation and mast cell cytokine production. J. Biol. Chem. 279 (2004) 49177-49187
23. Galli S.J. Complexity and redundancy in the pathogenesis of asthma: Reassessing the roles of mast cells and T cells. J. Exp. Med. 186 (1997) 343-347
24. Galli S.J. The mast cell: A versatile effector cell for a challenging world. Int. Arch. Allergy Immunol. 113 (1997) 14-22
25. Galli S.J., Kalesnikoff J., Grimbaldeston M.A., Piliponsky A.M., Williams C.M., and Tsai M. Mast cells as "tunable" effector and immunoregulatory cells: Recent advances. Annu. Rev. Immunol. 23 (2005) 749-786
26. Gilfillan A.M., and Tkaczyk C. Integrated signalling pathways for mast-cell activation. Nat. Rev. Immunol. 6 (2006) 218-230
27. Gomez G., Gonzalez-Espinosa C., Odom S., Baez G., Cid M.E., Ryan J.J., and Rivera J. Impaired FcεRI-dependent gene expression and defective eicosanoid and cytokine production as a consequence of Fyn-deficiency in mast cells. J. Immunol. 175 (2005) 7602-7610
28. Gonzalez-Espinosa C., Odom S., Olivera A., Hobson J.P., Martinez M.E., Oliveira-Dos-Santos A., Barra L., Spiegel S., Penninger J.M., and Rivera J. Preferential signaling and induction of allergy-promoting lymphokines upon weak stimulation of the high affinity IgE receptor on mast cells. J. Exp. Med. 197 (2003) 1453-1465
29. Gu H., Saito K., Klaman L.D., Shen J., Fleming T., Wang Y., Pratt J.C., Lin G., Lim B., Kinet J.P., and Neel B.G. Essential role for Gab2 in the allergic response. Nature 412 (2001) 186-190
30. Heneberg P., Lebduska P., Draberova L., Korb J., and Draber P. Topography of plasma membrane microdomains and its consequences for mast cell signaling. Eur. J. Immunol. 36 (2006) 2795-2806
31. Hernandez-Hansen V., Smith A.J., Surviladze Z., Chigaev A., Mazel T., Kalesnikoff J., Lowell C.A., Krystal G., Sklar L.A., Wilson B.S., and Oliver J.M. Dysregulated FcεRI signaling and altered Fyn and SHIP activities in Lyn-deficient mast cells. J. Immunol. 173 (2004) 100-112
32. Herz U., Renz H., and Wiedermann U. Animal models of type I allergy using recombinant allergens. Methods 32 (2004) 271-280
33. Hibbs M.L., Tarlinton D.M., Armes J., Grail D., Hodgson G., Maglitto R., Stacker S.A., and Dunn A.R. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell 83 (1995) 301-311
34. Hisatsune C., Kuroda Y., Nakamura K., Inoue T., Nakamura T., Michikawa T., Mizutani A., and Mikoshiba K. Regulation of TRPC6 channel activity by tyrosine phosphorylation. J. Biol. Chem. 279 (2004) 18887-18894
35. Hong H., Kitaura J., Xiao W., Horejsi V., Ra C., Lowell C.A., Kawakami Y., and Kawakami T. The Src family kinase Hck regulates mast cell activation by suppressing an inhibitory Src family kinase Lyn. Blood 110 (2007) 2511-2519
36. Hoth M., and Penner R. Depletion of intracellular calcium stores activates a calcium current in mast cells. Nature 355 (1992) 353-356
37. Houtman J.C., Barda-Saad M., and Samelson L.E. Examining multiprotein signaling complexes from all angles. Febs. J. 272 (2005) 5426-5435
38. Huber M., Helgason C.D., Damen J.E., Liu L., Humphries R.K., and Krystal G. The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation. Proc. Natl. Acad. Sci. USA 95 (1998) 11330-11335
39. Huber M., Helgason C.D., Scheid M.P., Duronio V., Humphries R.K., and Krystal G. Targeted disruption of SHIP leads to Steel factor-induced degranulation of mast cells. Embo J. 17 (1998) 7311-7319
40. Huber M., Kalesnikoff J., Reth M., and Krystal G. The role of SHIP in mast cell degranulation and IgE-induced mast cell survival. Immunol. Lett. 82 (2002) 17-21
41. Iwaki S., Spicka J., Tkaczyk C., Jensen B.M., Furumoto Y., Charles N., Kovarova M., Rivera J., Horejsi V., Metcalfe D.D., and Gilfillan A.M. Kit- and FcεRI-induced differential phosphorylation of the transmembrane adaptor molecule NTAL/LAB/LAT2 allows flexibility in its scaffolding function in mast cells. Cell Signal 20 (2008) 195-205
42. Jahn T., Leifheit E., Gooch S., Sindhu S., and Weinberg K. Lipid rafts are required for Kit survival and proliferation signals. Blood 110 (2007) 1739-1747
43. Jolly P., Rosenfeldt H., Milstien S., and Spiegel S. The roles of sphingosine-1-phosphate in asthma. Mol. Immunol. 38 (2002) 1239-1251
44. Jolly P.S., Bektas M., Olivera A., Gonzalez-Espinosa C., Proia R.L., Rivera J., Milstien S., and Spiegel S. Transactivation of sphingosine-1-phosphate receptors by FcεRI triggering is required for normal mast cell degranulation and chemotaxis. J. Exp. Med. 199 (2004) 959-970
45. Kawakami Y., Kitaura J., Satterthwaite A.B., Kato R.M., Asai K., Hartman S.E., Maeda-Yamamoto M., Lowell C.A., Rawlings D.J., Witte O.N., and Kawakami T. Redundant and opposing functions of two tyrosine kinases, Btk and Lyn, in mast cell activation. J. Immunol. 165 (2000) 1210-1219
46. Kihara H., and Siraganian R.P. Src homology 2 domains of Syk and Lyn bind to tyrosine-phosphorylated subunits of the high affinity IgE receptor. J. Biol. Chem. 269 (1994) 22427-22432
47. Kitano M., Hla T., Sekiguchi M., Kawahito Y., Yoshimura R., Miyazawa K., Iwasaki T., Sano H., Saba J.D., and Tam Y.Y. Sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 signaling in rheumatoid synovium: Regulation of synovial proliferation and inflammatory gene expression. Arthritis Rheum. 54 (2006) 742-753
48. Kitaura J., Kawakami Y., Maeda-Yamamoto M., Horejsi V., and Kawakami T. Dysregulation of Src family kinases in mast cells from epilepsy-resistant ASK versus epilepsy-prone EL mice. J. Immunol. 178 (2007) 455-462
49. Kovarova M., Tolar P., Arudchandran R., Draberova L., Rivera J., and Draber P. Structure-function analysis of Lyn kinase association with lipid rafts and initiation of early signaling events after Fcε receptor I aggregation. Mol. Cell Biol. 21 (2001) 8318-8328
50. Kovarova M., Wassif C.A., Odom S., Liao K., Porter F.D., and Rivera J. Cholesterol-deficiency in a murine model of Smith-Lemli-Opitz Syndrome reveals increased mast cell responsiveness. J. Exp. Med. 203 (2006) 1161-1171
51. Kraft S., and Kinet J.P. New developments in FcεRI regulation, function and inhibition. Nat. Rev. Immunol. 7 (2007) 365-378
52. Lee D.M., Friend D.S., Gurish M.F., Benoist C., Mathis D., and Brenner M.B. Mast cells: A cellular link between autoantibodies and inflammatory arthritis. Science 297 (2002) 1689-1692
53. Leung W.H., and Bolland S. The inositol 5′-phosphatase SHIP-2 negatively regulates IgE-induced mast cell degranulation and cytokine production. J. Immunol. 179 (2007) 95-102
54. 2+ influx. Curr. Biol. 15 (2005) 1235-1241
55. 2+, and degranulation in a rat mast cell line. J. Immunol. 180 (2008) 2233-2239
56. Martin-Verdeaux S., Pombo I., Iannascoli B., Roa M., Varin-Blank N., Rivera J., and Blank U. Analysis of Munc18-2 compartmentation in mast cells reveals a role for microtubules in granule exocytosis. J. Cell Sci. 116 (2003) 325-334
57. Mathes C., Fleig A., and Penner R. Calcium release-activated calcium current (ICRAC) is a direct target for sphingosine. J. Biol. Chem. 273 (1998) 25020-25030
58. Matloubian M., Lo C.G., Cinamon G., Lesneski M.J., Xu Y., Brinkmann V., Allende M.L., Proia R.L., and Cyster J.G. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427 (2004) 355-360
59. 2+ signals triggered by different phospholipid pathways in antigen stimulation of human mast cells. J. Biol. Chem. 277 (2002) 17255-17262
60. Metzger H. The IgE-mast cell system as a paradigm for the study of antibody mechanisms. Immunol. Rev. 41 (1978) 186-199
61. Metzger H. It's spring, and thoughts turn to ... allergies. Cell 97 (1999) 287-290
62. Nadler M.J., Matthews S.A., Turner H., and Kinet J.P. Signal transduction by the high-affinity immunoglobulin E receptor FcεRI: coupling form to function. Adv. Immunol. 76 (2000) 325-355
63. Nechushtan H., Leitges M., Cohen C., Kay G., and Razin E. Inhibition of degranulation and interleukin-6 production in mast cells derived from mice deficient in protein kinase Cβ. Blood 95 (2000) 1752-1757
64. Nishida K., Yamasaki S., Ito Y., Kabu K., Hattori K., Tezuka T., Nishizumi H., Kitamura D., Goitsuka R., Geha R.S., Yamamoto T., Yagi T., and Hirano T. FcεRI-mediated mast cell degranulation requires calcium-independent microtubule-dependent translocation of granules to the plasma membrane. J. Cell Biol. 170 (2005) 115-126
65. 2+ mobilization, but not degranulation, in Lyn-deficient bone marrow-derived mast cells. J. Immunol. 158 (1997) 2350-2355
66. O'Neill S.M., Brady M.T., Callanan J.J., Mulcahy G., Joyce P., Mills K.H., and Dalton J.P. Fasciola hepatica infection downregulates Th1 responses in mice. Parasite Immunol. 22 (2000) 147-155
67. Odom S., Gomez G., Kovarova M., Furumoto Y., Ryan J.J., Wright H.V., Gonzalez-Espinosa C., Hibbs M.L., Harder K.W., and Rivera J. Negative regulation of immunoglobulin E-dependent allergic responses by Lyn kinase. J. Exp. Med. 199 (2004) 1491-1502
68. Olivera A., Mizugishi K., Tikhonova A., Ciaccia L., Odom S., Proia R.L., and Rivera J. The sphingosine kinase-sphingosine-1-phosphate axis is a determinant of mast cell function and anaphylaxis. Immunity 26 (2007) 287-297
69. Olivera A., and Rivera J. Sphingolipids and the balancing of immune cell function: lessons from the mast cell. J. Immunol. 174 (2005) 1153-1158
70. Olivera A., Rosenthal J., and Spiegel S. Effect of acidic phospholipids on sphingosine kinase. J. Cell Biochem. 60 (1996) 529-537
71. Olivera A., Urtz N., Mizugishi K., Yamashita Y., Gilfillan A.M., Furumoto Y., Gu H., Proia R.L., Baumruker T., and Rivera J. IgE-dependent activation of sphingosine kinases 1 and 2 and secretion of sphingosine 1-phosphate requires Fyn kinase and contributes to mast cell responses. J. Biol. Chem. 281 (2006) 2515-2525
72. On M., Billingsley J.M., Jouvin M.H., and Kinet J.P. Molecular dissection of the FcRβ signaling amplifier. J. Biol. Chem. 279 (2004) 45782-45790
73. 2+-independent isozymes of protein kinase C mediate exocytosis in antigen-stimulated Rat Basophilic RBL-2H3 cells. J. Biol. Chem. 268 (1993) 1749-1756
74. Parravicini V., Gadina M., Kovarova M., Odom S., Gonzalez-Espinosa C., Furumoto Y., Saitoh S., Samelson L.E., O'Shea J.J., and Rivera J. Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation. Nat. Immunology 3 (2002) 741-748
75. 2+ entry. Cell 111 (2002) 529-541
76. Peinelt C., Vig M., Koomoa D.L., Beck A., Nadler M.J., Koblan-Huberson M., Lis A., Fleig A., Penner R., and Kinet J.P. Amplification of CRAC current by STIM1 and CRACM1 (Orai1). Nat. Cell Biol. 8 (2006) 771-773
77. Pivniouk V.I., Martin T.R., Lu-Kuo J.M., Katz H.R., Oettgen H.C., and Geha R.S. SLP-76 deficiency impairs signaling via the high-affinity IgE receptor in mast cells. J. Clin. Invest. 103 (1999) 1737-1743
78. Pombo I., Rivera J., and Blank U. Munc18-2/syntaxin3 complexes are spatially separated from syntaxin3-containing SNARE complexes. FEBS Lett. 550 (2003) 144-148
79. Prakriya M., Feske S., Gwack Y., Srikanth S., Rao A., and Hogan P.G. Orai1 is an essential pore subunit of the CRAC channel. Nature 443 (2006) 230-233
80. Pribluda V.S., Pribluda C., and Metzger H. Transphosphorylation as the mechanism by which the high-affinity receptor for IgE is phosphorylated upon aggregation. Proc. Natl. Acad. Sci. USA 91 (1994) 11246-11250
81. Prieschl E.E., Csonga R., Novotny V., Kikuchi G.E., and Baumruker T. The balance between sphingosine and sphingosine-1-phosphate is decisive for mast cell activation after Fcε receptor I triggering. J. Exp. Med. 190 (1999) 1-8
82. Puri N., and Roche P.A. Ternary SNARE complexes are enriched in lipid rafts during mast cell exocytosis. Traffic 7 (2006) 1482-1494
83. Putney Jr. J.W. A model for receptor-regulated calcium entry. Cell Calcium. 7 (1986) 1-12
84. Putney Jr. J.W., Takemura H., Hughes A.R., Horstman D.A., and Thastrup O. How do inositol phosphates regulate calcium signaling?. FASEB Journal 3 (1989) 1899-1905
85. Pyne S., and Pyne N. Sphingosine 1-phosphate signalling via the endothelial differentiation gene family of G-protein-coupled receptors. Pharmacol. Ther. 88 (2000) 115-131
86. Rivera J. Molecular adapters in FcεRI signaling and the allergic response. Curr. Opin. Immunol. 14 (2002) 688-693
87. Rivera J. NTAL/LAB and LAT: A balancing act in mast cell activation and function. Trends. Immunol. 26 (2005) 119-122
88. Rivera J., and Beaven M.A. In: Parker P.J., and Dekker L.V. (Eds). Protein Kinase C (1997), Landes Bioscience, Austin, TX 133-166
89. Rivera J., and Gilfillan A.M. Molecular regulation of mast cell activation. J. Allergy. Clin. Immunol. 117 (2006) 1214-1225 quiz 1226
90. Rivera J., Gonzalez-Espinosa C., Kovarova M., and Parravicini V. The Architecture of IgE-dependent mast cell signaling. A complex story. Allergy Clin. Immunol. Int. 14 (2002) 25-36
91. Rivera J., and Olivera A. Src family kinases and lipid mediators in control of allergic inflammation. Immunol. Rev. 217 (2007) 255-268
92. Rivera J., and Tessarollo L. Genetic background and the dilemma of translating mouse studies to humans. Immunity 28 (2008) 1-4
93. 2+ channel function. J. Cell Biol. 169 (2005) 435-445
94. Saitoh S., Arudchandran R., Manetz T.S., Zhang W., Sommers C.L., Love P.E., Rivera J., and Samelson L.E. LAT is essential for FcεRI-mediated mast cell activation. Immunity 12 (2000) 525-535
95. Saitoh S., Odom S., Gomez G., Sommers C.L., Young H.A., Rivera J., and Samelson L.E. The four distal tyrosines are required for LAT-dependent signaling in FcεRI-mediated mast cell activation. J. Exp. Med. 198 (2003) 831-843
96. Sheets E.D., Holowka D., and Baird B. Critical role for cholesterol in Lyn-mediated tyrosine phosphorylation of FcεRI and their association with detergent-resistant membranes. J. Cell Biol. 145 (1999) 877-887
97. Sil D., Lee J.B., Luo D., Holowka D., and Baird B. Trivalent ligands with rigid DNA spacers reveal structural requirements for IgE receptor signaling in RBL mast cells. ACS Chem. Biol. 2 (2007) 674-684
98. Silverman M.A., Shoag J., Wu J., and Koretzky G.A. Disruption of SLP-76 interaction with Gads inhibits dynamic clustering of SLP-76 and FcεRI signaling in mast cells. Mol. Cell Biol. 26 (2006) 1826-1838
99. Simons K., and Toomre D. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 1 (2000) 31-39
100. Siraganian R.P., Zhang J., Suzuki K., and Sada K. Protein tyrosine kinase Syk in mast cell signaling. Mol. Immunol. 38 (2002) 1229-1233
101. Smyth J.T., Dehaven W.I., Jones B.F., Mercer J.C., Trebak M., Vazquez G., and Putney Jr. J.W. Emerging perspectives in store-operated Ca(2+) entry: Roles of Orai, Stim and TRP. Biochim. Biophys. Acta. 1763 (2006) 1147-1160
102. Spiegel S., Foster D., and Kolesnick R. Signal transduction through lipid second messengers. Curr. Opin. Cell Biol. 8 (1996) 159-167
103. Spiegel S., and Milstien S. Sphingosine-1-phosphate: An enigmatic signalling lipid. Nat. Rev. Mol. Cell Biol. 4 (2003) 397-407
104. Swieter M., Berenstein E.H., and Siraganian R.P. Protein tyrosine phosphatase activity associates with the high affinity IgE receptor and dephosphorylates the receptor subunits, but not Lyn or Syk. J. Immunol. 155 (1995) 5330-5336
105. Tkaczyk C., Horejsi V., Iwaki S., Draber P., Samelson L.E., Satterthwaite A.B., Nahm D.-H., Metcalfe D.D., and Gilfillan A.M. NTAL phosphorylation is a pivotal link between the signaling cascades leading to human mast cell degranulation following KIT activation and FcεRI aggregation. Blood 104 (2004) 207-214
106. Tkaczyk C., Iwaki S., Metcalfe D.D., and Gilfillan A.M. Roles of adaptor molecules in mast cell activation. Chem. Imunnol. Allergy 87 (2005) 43-58
107. Torigoe C., Faeder J.R., Oliver J.M., and Goldstein B. Kinetic proofreading of ligand-FcεRI interactions may persist beyond LAT phosphorylation. J. Immunol. 178 (2007) 3530-3535
108. Torigoe C., Inman J.K., and Metzger H. An unusual mechanism for ligand antagonism. Science 281 (1998) 568-572
109. Urtz N., Olivera A., Bofill-Cardona E., Csonga R., Billich A., Mechtcheriakova D., Bornancin F., Woisetschlager M., Rivera J., and Baumruker T. Early activation of sphingosine kinase in mast cells and recruitment to FcεRI are mediated by its interaction with Lyn kinase. Mol. Cell Biol. 24 (2004) 8765-8777
110. Vazquez G., Wedel B.J., Kawasaki B.T., Bird G.S., and Putney Jr. J.W. Obligatory role of Src kinase in the signaling mechanism for TRPC3 cation channels. J. Biol. Chem. 279 (2004) 40521-40528
111. Vig M., Beck A., Billingsley J.M., Lis A., Parvez S., Peinelt C., Koomoa D.L., Soboloff J., Gill D.L., Fleig A., Kinet J.P., and Penner R. CRACM1 multimers form the ion-selective pore of the CRAC channel. Curr. Biol. 16 (2006) 2073-2079
112. Vig M., DeHaven W.I., Bird G.S., Billingsley J.M., Wang H., Rao P.E., Hutchings A.B., Jouvin M.H., Putney J.W., and Kinet J.P. Defective mast cell effector functions in mice lacking the CRACM1 pore subunit of store-operated calcium release-activated calcium channels. Nat. Immunol. 9 (2008) 89-96
113. Vig M., and Kinet J.P. The long and arduous road to CRAC. Cell Calcium 42 (2007) 157-162
114. Vig M., Peinelt C., Beck A., Koomoa D.L., Rabah D., Koblan-Huberson M., Kraft S., Turner H., Fleig A., Penner R., and Kinet J.P. CRACM1 is a plasma membrane protein essential for store-operated Ca2+ entry. Science 312 (2006) 1220-1223
115. Volna P., Lebduska P., Draberova L., Simova S., Heneberg P., Boubelik M., Bugajev V., Malissen B., Wilson B.S., Horejsi V., Malissen M., and Draber P. Negative regulation of mast cell signaling and function by the adaptor LAB/NTAL. J. Exp. Med. 200 (2004) 1001-1013
116. Vonakis B.M., Gibbons Jr. S.P., Rotte M.J., Brothers E.A., Kim S.C., Chichester K., and MacDonald S.M. Regulation of rat basophilic leukemia-2H3 mast cell secretion by a constitutive Lyn kinase interaction with the high affinity IgE receptor (FcεRI). J. Immunol. 175 (2005) 4543-4554
117. Wang D., Feng J., Wen R., Marine J.C., Sangster M.Y., Parganas E., Hoffmeyer A., Jackson C.W., Cleveland J.L., Murray P.J., and Ihle J.N. Phospholipase Cγ2 is essential in the functions of B cell and several Fc receptors. Immunity 13 (2000) 25-35
118. Williams C.M., and Galli S.J. The diverse potential effector and immunoregulatory roles of mast cells in allergic disease. J. Allergy Clin. Immunol. 105 (2000) 847-859
119. Wilson B.S., Pfeiffer J.R., and Oliver J.M. Observing FcεRI signaling from the inside of the mast cell membrane. J. Cell Biol. 149 (2000) 1131-1142
120. Wilson B.S., Pfeiffer J.R., Surviladze Z., Gaudet E.A., and Oliver J.M. High resolution mapping of mast cell membranes reveals primary and secondary domains of FcεRI and LAT. J. Cell Biol. 154 (2001) 645-658
121. Xiao W., Nishimoto H., Hong H., Kitaura J., Nunomura S., Maeda-Yamamoto M., Kawakami Y., Lowell C.A., Ra C., and Kawakami T. Positive and negative regulation of mast cell activation by Lyn via the FcεRI. J. Immunol. 175 (2005) 6885-6892
122. Yamashita Y., Charles N., Furumoto Y., Odom S., Yamashita T., Gilfillan A.M., Constant S., Bower M.A., Ryan J.J., and Rivera J. Cutting Edge: Genetic variation influences FcεRI-induced mast cell activation and allergic responses. J. Immunol. 179 (2007) 740-743
123. Young R.M., Holowka D., and Baird B. A lipid raft environment enhances Lyn kinase activity by protecting the active site tyrosine from dephosphorylation. J. Biol. Chem. 278 (2003) 20746-20752
124. Zemann B., Kinzel B., Muller M., Reuschel R., Mechtcheriakova D., Urtz N., Bornancin F., Baumruker T., and Billich A. Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720. Blood 107 (2006) 1454-1458
125. Zhang J., Berenstein E.H., Evans R.L., and Siraganian R.P. Transfection of Syk protein tyrosine kinase reconstitutes high affinity IgE receptor-mediated degranulation in a Syk-negative variant of rat basophilic leukemia RBL-2H3 cells. J. Exp. Med. 184 (1996) 71-79
126. Zhang J., Kimura T., and Siraganian R.P. Mutations in the activation loop tyrosines of protein tyrosine kinase Syk abrogate intracellular signaling but not kinase activity. J. Immunol. 161 (1998) 4366-4374
127. Zhu M., Koonpaew S., Liu Y., Shen S., Denning T., Dzhagalov I., Rhee I., and Zhang W. Negative regulation of T cell activation and autoimmunity by the transmembrane adaptor protein LAB. Immunity 25 (2006) 757-768
128. Zhu M., Liu Y., Koonpaew S., Ganillo O., and Zhang W. Positive and negative regulation of FcεRI-mediated signaling by the adaptor protein LAB/NTAL. J. Exp. Med. 200 (2004) 991-1000